Compositions having improved stability

Details for Australian Patent Application No. 2004200445 (hide)

Owner The Procter & Gamble Company

Inventors Dobrozsi, Douglas Joseph

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004200445

Parent 28475

Filing date 6 February 2004

Wipo publication date 4 March 2004

International Classifications

A61K 031/485 - Morphinan derivatives, e.g. morphine, codeine

A61K 047/10 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 009/00 Medicinal preparations characterised by special physical form

A61P 011/14 Drugs for disorders of the respiratory system

Event Publications

26 February 2004 Complete Application Filed

4 March 2004 Application Open to Public Inspection

  Published as AU-A-2004200445

4 August 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004200446-Substituted 6-Benzyl-4-Oxopyrimidines, process for their preparation and pharmaceutical compositions containing them

2004200444-Combination of antigen pulsed APCS and interleukin 12 for tumor and viral therapy